← Back to all signals
MDT · Q2 2026

Medtronic plc

Reported 2026-06-03
BEAT
51EarnIQ signal

Confidence rising

Mild quarter-over-quarter shift

Medtronic delivered its strongest revenue growth in a decade, backed by robust cardiac ablation momentum and confident FY27 guidance.

  • Guidance was none, with high specificity.
  • Management tone registered as confident (88/100).
  • EarnIQ detected 0 potential management deflections.
Headline–confidence gap

Headline confirmed

Management confidence reinforces the reported beat.

EPS: reported vs expected— vs —
Revenue: reported vs expected— vs —
Guidance specificityHighChange not comparable
Market expectations are being matched to this report.

Our performance reflects the strongest annual top-line growth Medtronic has delivered in 10 years, powered by disciplined execution across our portfolio and continued operational rigor.

EarnIQ Premium

Understand exactly why confidence changed.

Unlock management-language evidence, guidance specificity, the pressure point, narrative breaks, risks, and quarter-over-quarter topic changes.

Guidance specificityPressure pointNarrative breakSource evidence
Preview full report